Used as a key intermediate in the synthesis of fluorinated quinoline-based pharmaceuticals, particularly in the development of antimalarial and antibacterial agents. Its structure supports enhanced bioavailability and binding affinity to target enzymes in pathogens. Also employed in research for novel kinase inhibitors due to its ability to modulate signaling pathways involved in cancer progression. The compound's fluorine atoms improve metabolic stability, making it valuable in medicinal chemistry for optimizing drug candidates.